Serono to Discuss Application Front Ends’ Role in Successful Domino Web Application Deployment at Lotusphere 2005

Redline Networks’ Application Front End Network Appliances Boost Biotechnology Company’s Server Capacity by 500 Percent and Reduce Page Download Times by up to 70 Percent

Redline Networks, Inc., a company that designs and manufactures network appliances that maximize the performance, availability and security of Web-enabled applications, today announced that Rael Paster, head of collaboration services at Serono, will discuss Redline Networks’ part in Serono’s successful Domino Web Access deployment during a session entitled “Successful Deployment of Domino Web Access” at Lotusphere 2005 on Thursday, January 27 at 10 a.m.

Mr. Paster will share how and why Serono selected Redline Networks to boost the performance of several business critical Web-based applications. In addition, Mr. Paster will share how Redline Networks’ application front end network appliances help to mitigate “pain points” associated with Web-enabled applications. Some of the pain points Mr. Paster will address include challenges associated with user response time/performance; high availability/reliability; scalability of Web servers and bandwidth utilization and/or cost.

Copies of Mr. Paster’s Lotusphere presentation will be available from Redline Networks January 31, 2005. Please visit http://www.RedlineNetworks.com. -0- *T RECAP FOR EVENT CALENDARS: Event: Serono to Discuss Web-Enabled Application Deployment at Lotusphere 2005 Date: Thursday, January 27, 2005 Time: 10 a.m. – 11 a.m. Location: Lotusphere 2005, Walt Disney World(R) Resort, Orlando, FL SW Mocking Bird Speakers: Rael Paster, head of collaboration services at Serono; Jason Dumont, Lotus Software, IBM Software Group Topic: Successful Deployment of Domino Web Access Session ID: CS107 Session Track: Track Five, Customer Case Studies *T

About Serono

Serono is a global biotechnology leader. The Company has eight biotechnology products, Rebif(R), Gonal-F(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R). In addition to being the world leader in reproductive health, Serono has strong market positions in neurology, metabolism and growth and has recently entered the psoriasis area. The Company’s research programs are focused on growing these businesses and on establishing new therapeutic areas. Currently, there are approximately 30 ongoing development projects. In 2003, Serono achieved worldwide revenues of US$2,018.6 million, and a net income of US$390.0 million, making it the third largest biotech company in the world. Its products are sold in over 90 countries. Bearer shares of Serono S.A., the holding company, are traded on the virt-x (SEO) and its American Depositary Shares are traded on the New York Stock Exchange (SRA).

About Redline Networks

Redline Networks designs and manufactures network appliances that maximize the performance, flexibility, availability, security and scalability of Web-enabled applications. The company’s family of E|X application front end network appliances, deployed at corporate data centers, and T|X Web I/O processors, used by Web sites, enable users to control and customize any HTTP-based environment while reducing infrastructure cost and complexity. Redline Networks is a privately-held company based in Campbell, Calif. For more information on Redline Networks and its products, visit http://www.RedlineNetworks.com.